Same Indication

Osimertinib vs Sitagliptin

Osimertinib vs Sitagliptin: Overview

This comparison examines the pharmacological differences between Osimertinib and Sitagliptin.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Sitagliptin: DPP-4 inhibitor increasing incretin levels.

Pharmacokinetics

Half-life: Osimertinib — 48 hours; Sitagliptin — 12.4 hours.

Chemical Properties

Molecular Formula: Osimertinib — C28H33N7O2; Sitagliptin — C16H15F6N5O.

Molecular Weight: Osimertinib — 499.6050 g/mol; Sitagliptin — 407.3140 g/mol.

Type: Osimertinib — Small molecule; Sitagliptin — Small molecule.